Jimena Rivas, MD
Obstetrics & Gynecology · Flemington, NJNPI 1366811978
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $224 of the $258 with a category attached, or 86.5%. It is spread thinly across 12 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $147 and has fallen 73.5% since, to $39 in 2024. That places this record below the midpoint for obstetrics & gynecology clinicians in NJ, where the typical reported total is $534.
Across 17 payments — averaging $15.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AMAG Pharmaceuticals, Inc.$35
- Therapeuticsmd, Inc.$35
- AbbVie$28
- GSK$27
- Avion Pharmaceuticals$26
- Medtronic$24
- plus $84 from 6 others
What the payments were for
- Food & beverage$22487%
- Education$3513%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AMAG Pharmaceuticals, Inc. | 2 | $35 |
| Therapeuticsmd, Inc. | 2 | $35 |
| AbbVie | 2 | $28 |
| GSK | 2 | $27 |
| Avion Pharmaceuticals | 2 | $26 |
| Medtronic | 1 | $24 |
| Lupin Inc. | 1 | $21 |
| Coloplast | 1 | $15 |
| Organon | 1 | $15 |
| Bayer | 1 | $14 |
| Exeltis, USA Inc. | 1 | $14 |
| Alydia Health | 1 | $6 |
How this compares
$258 in reported general payments places this provider in the 30th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 91 | $7,929 |
| MyrbetriqMirabegron | 12 | $5,418 |
| ProgesteroneProgesterone, Micronized | 16 | $1,332 |
| Clobetasol Propionate | 15 | $699 |
| Alendronate Sodium | 18 | $128 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Flemington
- Seth RubinFlemington$19K
- Jennifer AshtonEnglewood$1.5M
- Geoffrey BowersVoorhees$228K
- Neha DeshpandePlainsboro$206K
- Paula JasionowskiVoorhees$193K
- Justin ChuraSwedesboro$179K
- Andrea VentolaFlorham Park$145K
- Aiman ShiladPaterson$100K
- Patrick CulliganMorristown$93K
- Dipak DelvadiaCherry Hill$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.